1. News | 2019.06.04

   Icypro, an advanced bioimage analysis platform for health technology professionals

   The aim of the Icypro project is to transfer the expertise and advanced bioimage analysis solutions developed at the Institut Pasteur to fields where they will have a real impact for patients, such as diagnostics, medtech and drug discovery. On May 21, 2019, all the Icypro project partners and funders gathered at the Institut Pasteur for the official project launch.Winner of the 2018 SESAME...

2. News | 2019.06.13

   Human contact plays big role in spread of some hospital infections, but not others

   An observational study conducted in a French hospital showed that human contact was responsible for 90 percent of the spread of one species of antibiotic-resistant bacteria to new patients, but less than 60 percent of the spread of a different species. These findings suggest hand hygiene is a key, but more methods are needed to fight multidrug-resistant infection. Audrey Duval of the Versailles...

3. News | 2019.06.14

   Ceremony for the 2019 Pasteur Vallery-Radot Prize (awarded by the BnF)

   The National Library of France (BnF) has awarded the 2019 Pasteur Vallery-Radot Prize to Institut Pasteur scientists Guillaume Duménil and Rogerio Amino. The winners were invited by BnF President Laurence Engel to receive their awards on June 13, 2019, at a ceremony held in the BnF Richelieu Library and attended by Daniel Louvard, a member of the French Academy of Sciences, and Stewart Cole,...

4. News | 2019.07.12

   Sex-based differences influence chronicity in urinary tract infections

   Research efforts in recent years have highlighted that sex - being a woman or a man - can have a strong influence on how humans and animals respond to many types of infections. Researchers at the Institut Pasteur have identified a sex-based difference in the early immune response to infection in a model of urinary tract infection in female and male animals. Interview "Tête-à-tête" with Molly...

5. Article | 2019.06.14

   The Institut Pasteur Online Diploma in Infectious Diseases (DNM2IP)

   Enroll now

6. Report | 2019.06.17

   At the heart of the brain

   Fifteen researchers from around the world have come to work at Sandrine Etienne-Manneville’s laboratory at the Institut Pasteur. Their brief is to study astrocytes, star-shaped brain cells that support neurons. These cells can become cancerous, causing severe brain tumors known as gliomas, which are the primary cause of childhood cancer mortality ahead of leukemia, with 3,000 new cases diagnosed...

7. News | 2019.06.07

   Fondation IPSEN supports new MOOCs at the Institut Pasteur

   The Foundation IPSEN, an organization committed to promoting scientific knowledge among the general public, has become a new Institut Pasteur sponsor. It will support the production of around 15 new MOOCs and the creation of an online diploma in public health.The Institut Pasteur is a leading producer of MOOCs (massive open online courses) in life sciences and health, with specific content aimed...

8. News | 2019.06.18

   Vaccines: a life insurance for humankind

   France would be more suspicious of vaccines than more than 140 other countries, according to a global survey into how people around the world think and feel about science and major health challenges, published on June 19th, 2019. However, vaccines have made a key, cost-effective contribution to the prolongation of life expectancy and quality. Nowadays, vaccinology and immunology are facing...

9. Fiche maladie | 2019.06.25

   Kaposi’s sarcoma

   Kaposi’s sarcoma (KS) is caused by infection with human herpesvirus-8 (HHV-8). Although KS can occur independently of HIV/AIDS, it frequently develops in individuals co-infected with HIV and HHV-8. The AIDS epidemic has therefore led to a huge rise in the number of cases of Kaposi’s sarcoma, especially in regions of Africa where HHV-8 is endemic.

10. Fiche maladie | 2019.06.25

    HTLV-I

    HTLV-1 was the first human retrovirus to be discovered – it was isolated in 1980 by Robert Gallo's team in the United States. In 5% of cases, infected individuals go on to develop leukemia or a myeloneuropathy. Ten to twenty million people are infected by the virus worldwide. The major areas of endemic HTLV-1 infection are south-west Japan, the Caribbean, Latin America and tropical Africa.

Pages